Characterization and Clinical Management of Dilated Cardiomyopathy

Dilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (232 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545487904498
ctrlnum (CKB)5400000000043722
(oapen)https://directory.doabooks.org/handle/20.500.12854/68283
(EXLCZ)995400000000043722
collection bib_alma
record_format marc
spelling Merlo, Marco edt
Characterization and Clinical Management of Dilated Cardiomyopathy
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (232 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Dilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis and uninterrupted and tailored follow-up under constant optimal medical and non-pharmacological evidence-based treatments. Nevertheless, DCM is still one of the most common causes of heart transplantation in the western world. Clinical management requires an integrated and systematic use of diagnostic tools and a deeper investigation of the basic mechanisms underlying the disease. However, several emerging issues remain debated. Specifically, the genotype–phenotype correlation, the role of advanced imaging techniques and genetic testing, the lack of appropriate risk stratification models, the need for a multiparametric and multidisciplinary approach for device implantation, and a continuous reclassification of the disease during follow-up remain challenging issues in clinical practice. Therefore, the aim of this Special Issue is to shed the light on the most recent advancements in characterization and clinical management of DCM in order to unveil the conundrum of this particular disease.
English
Medicine bicssc
SCN5A
cardiac sodium channel
cardiac channelopathy
dilated cardiomyopathy
precision medicine
arrhythmias
atrial fibrillation
cardiomyopathy
heart failure
supraventricular arrhythmia
systolic dysfunction
tachycardiomyopathy
ventricular arrhythmia
left atrial strain
cardiac resynchronization therapy
muscular dystrophy
calcium
heart
gene therapy
phospholamban
Serca2a
mdx
oxidative stress
membrane stabilization
left ventricular noncompaction
congenital heart disease
congestive heart failure
non-ischemic cardiomyopathy
genetics
desmin
mitochondrial dysfunction
myopathy
whole exome sequencing
laminopathy
LMNA
biomarkers
troponin T
NT-proBNP
malignant ventricular arrhythmia
arrhythmic risk stratification
DNA methylation
alternative splicing
epigenetics
nonischemic dilated cardiomyopathy
cardiac magnetic resonance imaging
late gadolinium enhancement
long axis strain
left ventricle sphericity index
major adverse cardiovascular events
sex differences
left ventricular reverse remodelling
long-term outcomes
left ventricle non-compaction cardiomyopathy
cardiac magnetic resonance
titin
RNA binding motif protein 20 (RBM20)
sarcomere
diastolic dysfunction
phosphorylation
non-sense mRNA decay
mammalian target of rapamycin (mTOR) complex-1
duchenne muscular distrophy
3-03943-761-5
3-03943-762-3
Merlo, Marco oth
language English
format eBook
author2 Merlo, Marco
author_facet Merlo, Marco
author2_variant m m mm
author2_role Sonstige
title Characterization and Clinical Management of Dilated Cardiomyopathy
spellingShingle Characterization and Clinical Management of Dilated Cardiomyopathy
title_full Characterization and Clinical Management of Dilated Cardiomyopathy
title_fullStr Characterization and Clinical Management of Dilated Cardiomyopathy
title_full_unstemmed Characterization and Clinical Management of Dilated Cardiomyopathy
title_auth Characterization and Clinical Management of Dilated Cardiomyopathy
title_new Characterization and Clinical Management of Dilated Cardiomyopathy
title_sort characterization and clinical management of dilated cardiomyopathy
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (232 p.)
isbn 3-03943-761-5
3-03943-762-3
illustrated Not Illustrated
work_keys_str_mv AT merlomarco characterizationandclinicalmanagementofdilatedcardiomyopathy
status_str n
ids_txt_mv (CKB)5400000000043722
(oapen)https://directory.doabooks.org/handle/20.500.12854/68283
(EXLCZ)995400000000043722
carrierType_str_mv cr
is_hierarchy_title Characterization and Clinical Management of Dilated Cardiomyopathy
author2_original_writing_str_mv noLinkedField
_version_ 1787548718259503105
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04480nam-a2201033z--4500</leader><controlfield tag="001">993545487904498</controlfield><controlfield tag="005">20231214133445.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043722</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68283</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043722</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Merlo, Marco</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Characterization and Clinical Management of Dilated Cardiomyopathy</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (232 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Dilated cardiomyopathy (DCM) is a particular phenotype of non-ischemic systolic heart failure, frequently recognizing a genetic background and affecting relatively young patients with few comorbidities. Nowadays, long-term survival of DCM patients has been markedly improved due to an early diagnosis and uninterrupted and tailored follow-up under constant optimal medical and non-pharmacological evidence-based treatments. Nevertheless, DCM is still one of the most common causes of heart transplantation in the western world. Clinical management requires an integrated and systematic use of diagnostic tools and a deeper investigation of the basic mechanisms underlying the disease. However, several emerging issues remain debated. Specifically, the genotype–phenotype correlation, the role of advanced imaging techniques and genetic testing, the lack of appropriate risk stratification models, the need for a multiparametric and multidisciplinary approach for device implantation, and a continuous reclassification of the disease during follow-up remain challenging issues in clinical practice. Therefore, the aim of this Special Issue is to shed the light on the most recent advancements in characterization and clinical management of DCM in order to unveil the conundrum of this particular disease.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">SCN5A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac sodium channel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac channelopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dilated cardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">precision medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arrhythmias</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">atrial fibrillation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heart failure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">supraventricular arrhythmia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">systolic dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tachycardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ventricular arrhythmia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left atrial strain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac resynchronization therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">muscular dystrophy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">calcium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heart</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phospholamban</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Serca2a</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mdx</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oxidative stress</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">membrane stabilization</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left ventricular noncompaction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">congenital heart disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">congestive heart failure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-ischemic cardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">desmin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mitochondrial dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">myopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">whole exome sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">laminopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">LMNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">troponin T</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NT-proBNP</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">malignant ventricular arrhythmia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">arrhythmic risk stratification</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">alternative splicing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">epigenetics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nonischemic dilated cardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac magnetic resonance imaging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">late gadolinium enhancement</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long axis strain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left ventricle sphericity index</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">major adverse cardiovascular events</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sex differences</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left ventricular reverse remodelling</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">long-term outcomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">left ventricle non-compaction cardiomyopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cardiac magnetic resonance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">titin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RNA binding motif protein 20 (RBM20)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sarcomere</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diastolic dysfunction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phosphorylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-sense mRNA decay</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mammalian target of rapamycin (mTOR) complex-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">duchenne muscular distrophy</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-761-5</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-762-3</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Merlo, Marco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:54:36 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337928950004498&amp;Force_direct=true</subfield><subfield code="Z">5337928950004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337928950004498</subfield></datafield></record></collection>